Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ricola labeling deferral

This article was originally published in The Tan Sheet

Executive Summary

FDA is granting Ricola until Dec. 31 to comply with "Drug Facts" labeling requirements for its 10-count stick of Ricola Natural Herb Cough Drops, according to an Aug. 7 letter to Swiss firm. Ricola requested labeling deferral June 11 due to its "mistaken belief that [FDA] would exempt smaller packages such as its 10-count stick" SKU from the OTC labeling final rule. "Once it became aware" on April 10 the cough drops would not be considered a "convenience-size" package, firm said it began developing new labeling to comply with final reg, but needs additional time to make changes. "Drug Facts" labeling took effect for most OTCs May 16 (1"The Tan Sheet" May 20, 2002, p. 8)...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS094462

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel